{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:14:45Z","timestamp":1784214885901,"version":"3.55.0"},"reference-count":33,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.5582\/ddt.2025.01108","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:08:29Z","timestamp":1761170909000},"page":"277-284","source":"Crossref","is-referenced-by-count":1,"title":["Changing epidemiology of respiratory pathogens since 2020: Shenzhen case study and global perspectives"],"prefix":"10.5582","volume":"19","author":[{"given":"Chun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, National Clinical Research Center for Infectious Disease, Shenzhen Third People&apos;s Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, National Clinical Research Center for Infectious Disease, Shenzhen Third People&apos;s Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health, Shenzhen University Medical School, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Clinical Research Center for Infectious Disease, Shenzhen Third People&apos;s Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, National Clinical Research Center for Infectious Disease, Shenzhen Third People&apos;s Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Del Riccio M, Caini S, Bonaccorsi G, Lorini C, Paget J, van der Velden K, Meijer A, Haag M, McGovern I, Zanobini P. Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS). Int J Infect Dis. 2024; 144:107052.","DOI":"10.1016\/j.ijid.2024.107052"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lee SS, Viboud C, Petersen E. Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control. Int J Infect Dis. 2022; 122:1002-1004.","DOI":"10.1016\/j.ijid.2022.08.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Khan T, Das RS, Jaiswal A, Halder S, Majhi RM, Mahato A, Ghosh T, Satpathi P, Bhattacharya SD. Epidemiology and surveillance of influenza, RSV and SARS-CoV-2 in children admitted with severe acute respiratory infection in West bengal, India from 2022 to 2023. BMC Infect Dis. 2025; 25:1047.","DOI":"10.1186\/s12879-025-11421-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Olivares Barraza MF, Fasce RA, Nogareda F, Marcenac P, Vergara Mallegas N, Bustos Alister P, Loayza S, Chard AN, Arriola CS, Couto P, Garc\u00eda Calavaro C, Rodriguez A, Wentworth DE, Cuadrado C, Azziz-Baumgartner E. Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season - Chile, 2022. MMWR Morb Mortal Wkly Rep. 2022; 71:1353-1358.","DOI":"10.15585\/mmwr.mm7143a1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Franco FC, Souza M, Fernandes SM, Dias AC, Passos YG, Fiaccadori FS. Influenza A, influenza B, and SARS-COV-2 circulation patterns in midwest Brazil during the 2022-2023 period. Braz J Microbiol. 2024; 55:3027-3030.","DOI":"10.1007\/s42770-024-01381-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fossum E, Rohringer A, Aune T, Rydland KM, Bragstad K, Hungnes O. Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023. Virol J. 2024; 21:57.","DOI":"10.1186\/s12985-024-02341-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Broberg EK, Svartstr\u00f6m O, Riess M, Kraus A, Vukovikj M, Melidou A; Members of the European Reference Laboratory Network for Human Influenza (ERLI-Net); Collaborators. Co-circulation of seasonal influenza A(H1N1)pdm09, A(H3N2) and B\/Victoria lineage viruses with further genetic diversification, EU\/EEA, 2022\/23 influenza season. Euro Surveill. 2024; 29:2400020.","DOI":"10.2807\/1560-7917.ES.2024.29.39.2400020"},{"key":"8","unstructured":"8. European Centre for Disease Prevention and Control. Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU\/EEA.<i>https:\/\/www.ecdc.europa.eu\/en\/publications-data\/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital<\/i>. (accessed September 29, 2025)"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Leija-Mart\u00ednez JJ, Cadena-Mota S, Gonz\u00e1lez-Ortiz AM, Mu\u00f1oz-Escalante JC, Mata-Moreno G, Hern\u00e1ndez-S\u00e1nchez PG, Vega-Mor\u00faa M, Noyola DE. Respiratory Syncytial Virus and Other Respiratory Viruses in Hospitalized Infants During the 2023-2024 Winter Season in Mexico. Viruses. 2024; 16:1917.","DOI":"10.3390\/v16121917"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Abu-Raya B, Vi\u00f1eta Paramo M, Reicherz F, Lavoie PM. Why has the epidemiology of RSV changed during the COVID-19 pandemic? EClinicalMedicine. 2023; 61:102089.","DOI":"10.1016\/j.eclinm.2023.102089"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miyama T, Kakimoto K, Yamanaka Y, Nishida Y, Iritani N, Motomura K. Irregular seasonality of respiratory syncytial virus infection persists in 2023 in Osaka, Japan. IJID Reg. 2024; 13:100442.","DOI":"10.1016\/j.ijregi.2024.100442"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhao C, Zhang T, Guo L,<i>et al<\/i>. Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic. Nat Commun. 2025; 16:1610.","DOI":"10.1038\/s41467-025-56776-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wang C, Yang Y, Wu K, Wang C, Liu W, Zhu Y, Ye L, Li X, Zhou R, Zhu B, Tian X. An Outbreak of Human Adenovirus Infection Among Children Post COVID-19 Pandemic in Southern China. J Med Virol. 2024; 96:e70139.","DOI":"10.1002\/jmv.70139"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bin Saleh K, Badreldin HA, Alqahtani T, <i>et al<\/i>. Assessing the influence of COVID-19 on influenza prevalence: A multicenter time series study. J Infect Public Health. 2023; 16:1989-1993.","DOI":"10.1016\/j.jiph.2023.09.018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020; 117:30547-30553.","DOI":"10.1073\/pnas.2013182117"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hirotsu Y, Nagakubo Y, Maejima M, Shibusawa M, Hosaka K, Sueki H, Mochizuki H, Omata M. Changes in Viral Dynamics Following the Legal Relaxation of COVID-19 Mitigation Measures in Japan From Children to Adults: A Single Center Study, 2020-2023. Influenza Other Respir Viruses. 2024; 18:e13278.","DOI":"10.1111\/irv.13278"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zeng H, Cai M, Li S, Chen X, Xu X, Xie W, Xiong Y, Long X. Epidemiological characteristics of seasonal influenza under implementation of zero-COVID-19 strategy in China. J Infect Public Health. 2023; 16:1158-1166.","DOI":"10.1016\/j.jiph.2023.05.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Piret J, Boivin G. Viral Interference between Respiratory Viruses. Emerg Infect Dis. 2022; 28:273-281.","DOI":"10.3201\/eid2802.211727"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Luo W, Liu Q, Zhou Y, Ran Y, Liu Z, Hou W, Pei S, Lai S. Spatiotemporal variations of &quot;triple-demic&quot; outbreaks of respiratory infections in the United States in the post-COVID-19 era. BMC Public Health. 2023; 23:2452.","DOI":"10.1186\/s12889-023-17406-9"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Shi W, Wohlwend J, Wu M, Barzilay R. Influenza vaccine strain selection with an AI-based evolutionary and antigenicity model. Nat Med. 2025. doi: 10.1038\/s41591-025-03917-y.","DOI":"10.1038\/s41591-025-03917-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lou J, Liang W, Cao L, <i>et al<\/i>. Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations. Nat Commun. 2024; 15:2546.","DOI":"10.1038\/s41467-024-46918-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gao C, Wen F, Guan M, Hatuwal B, Li L, Praena B, Tang CY, Zhang J, Luo F, Xie H, Webby R, Tao YJ, Wan XF. MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine production. Nat Commun. 2024; 15:1128.","DOI":"10.1038\/s41467-024-45145-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chan EMG, Boehm AB. Respiratory Virus Season Surveillance in the United States Using Wastewater Metrics, 2023-2024. ACS ES T Water. 2025; 5:985-992.","DOI":"10.1021\/acsestwater.4c01013"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zhang Z, Li Q, He F, Wang Z, Zhu C, Tu J, Li H, Yi L, Deng Y, Fu S. Sewage surveillance revealed the seasonality and prevalence of respiratory syncytial virus and its implications for seasonal immunization strategy in low and middle-income regions of China. Water Res. 270:122828.","DOI":"10.1016\/j.watres.2024.122828"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yang S, Dong Q, Li S, <i>et al<\/i>. Persistence of SARS-CoV-2 RNA in wastewater after the end of the COVID-19 epidemics. J Hazard Mater. 2022; 429:128358.","DOI":"10.1016\/j.jhazmat.2022.128358"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rodr\u00edguez A, Kamarthi H, Agarwal P, Ho J, Patel M, Sapre S, Prakash BA. Machine learning for data-centric epidemic forecasting. Nat Mach Intell. 2024; 6:1122-1131.","DOI":"10.1038\/s42256-024-00895-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhang T, Rabhi F, Chen X, Paik HY, MacIntyre CR. A machine learning-based universal outbreak risk prediction tool. Comput Biol Med. 2024; 169:107876.","DOI":"10.1016\/j.compbiomed.2023.107876"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wang L, Xie Q, Yu P, Zhang J, He C, Huang W, Wang Y, Zhao C. Research Progress of Universal Influenza Vaccine. Vaccines (Basel). 2025; 13:863.","DOI":"10.3390\/vaccines13080863"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cnossen VM, Moreira PCL, Engelhardt OG, <i>et al<\/i>. Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium. Front Immunol. 2025; 16:1568778.","DOI":"10.3389\/fimmu.2025.1568778"},{"key":"30","unstructured":"30. Liu XX, Song YF, Zhang ZN, <i>et al<\/i>. Analysis of estimated reported coverage of influenza vaccine in China in flu season 2014-2021. Chin J Viral Dis. 2023; 13:226-232. (in Chinese)"},{"key":"31","unstructured":"31. Centers for Disease Control and Prevention (CDC). Flu Vaccination Coverage, United States, 2020-2021 Influenza Season. <i>https:\/\/www.cdc.gov\/flu\/fluvaxview\/coverage-2021estimates.htm<\/i>. (accessed October 17, 2025)"},{"key":"32","unstructured":"32. World Health Organization.WHO Seasonal Influenza Vaccine Global Market Study, January 2024. <i>https:\/\/www.who.int\/publications\/m\/item\/who-seasonal-influenza-vaccine-global-market-study-january-2024<\/i>. (accessed October 17, 2025)"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C; Global Seasonal Influenza-associated Mortality Collaborator Network and GLaMOR Collaborating Teams. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019; 9:020421.","DOI":"10.7189\/jogh.09.020421"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/5\/19_2025.01108\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:12:05Z","timestamp":1763179925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/5\/19_2025.01108\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01108","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"2025.01108"}}